Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03529045 · ClinicalTrials.gov registry record
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
A clinical trial, sponsored by LivaNova.
- Completed
- Registry status
- 827
- Enrollment target
NCT03529045 is a clinical trial that has completed, run by LivaNova. The registered enrollment target is 827 participants.
The verdict
NCT03529045 has completed, sponsored by LivaNova.
- COMPLETED
- Registry status
- 827 participants
- Enrollment target
Study Summary
Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.
Interventions
- DEVICE Vagus Nerve Stimulation (VNS) Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 827 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2024-09-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03529045
The ClinicalTrials.gov registry entry for NCT03529045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 827 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LivaNova, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vagus Nerve Stimulation (VNS) Therapy is the first listed.
NCT03529045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03529045 about?
NCT03529045 is a clinical study titled "Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.". Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.
What is the current status of trial NCT03529045?
This trial is currently completed. The enrollment target is 827 participants. The study started on 2018-02-05. Estimated completion is 2024-09-11.
What interventions are being tested in trial NCT03529045?
The interventions under investigation include: Vagus Nerve Stimulation (VNS) Therapy (DEVICE).
Who is sponsoring clinical trial NCT03529045?
This trial is sponsored by LivaNova, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.